About Lloyd Segal
Lloyd Segal is a director at Aktis Oncology.
Lloyd Segal reports to the SEC as a director or officer of 3 public companies, including Repare Therapeutics (RPTX) and Bausch Health Companies (BHC).
Lloyd Segal first appears on SEC filings in 2010.
Experience
This experience comes from SEC filings. The years are when the filings name Lloyd Segal in the role, so the role may have started earlier or lasted longer.
RI
Repare Therapeutics Inc.
PRESIDENT and CEO, director
2020 – 2025 · Public company (RPTX)
BI
Bausch Health Companies Inc.
Director
2010 – 2013 · Public company (BHC)
Key Colleagues at Startups
The people Lloyd Segal works with at each company, as listed on that company's latest Form D.
Aktis Oncology, Inc. · Form D, Oct 2, 2024
HK
Helen Kim
Director
SB
Shulamit Ron-Bigger
Executive officer
KH
Ken Herrmann
Director
ON
Oleg Nodelman
Director
AL
Andrew Levin
Director
MR
Matthew Roden
CEO and director
TF
Todd Foley
Director